Avita Medical | 1811094D - Current Assets



Avita Medical reported AUD57M in Current Assets for its fiscal semester ending in December of 2024.


Current Assets Change Date
Adcock Ingram Holdings ZAR 5.12B 234.71M Dec/2024
Celltrion KRW 5.46T 122.95B Mar/2025
Clinuvel Pharmaceuticals AUD 222.06M 20.56M Jun/2024
Cochlear AUD 1.41B 41.5M Dec/2024
CSL USD 11.31B 540M Dec/2024
Cspc Pharmaceutical CNY 21.89B 4.58B Dec/2024
Dianthus Therapeutics USD 263.6M 17.3M Jun/2025
Divis Laboratories Ltd 100.81B 7.4B Mar/2025
Kangmei Pharma CNY 6.9B 6.92M Jun/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Laboratorios Farma EUR 516.3M 26.69M Jun/2025
Malin Corporation EUR 62.6M 26.7M Dec/2024
Mayne Pharma AUD 460.59M 14.71M Jun/2024
Medical Developments International AUD 33.41M 7.26M Dec/2024
Nanosonics AUD 210.09M 11.64M Dec/2024
Neuren Pharmaceuticals AUD 399.33M 171.29M Dec/2024
Organigram Holdings CAD 277.78M 46.29M Jun/2025
Pacific Edge NZD 30.82M 13.49M Mar/2025
Paradigm Biopharmaceuticals AUD 32.29M 8.04M Dec/2024
Pharma Mar EUR 249.4M 13.39M Jun/2025
Polynovo AUD 79.3M 9.02M Jun/2024
PYC Therapeutics AUD 62.12M 23.49M Dec/2024
Qiagen NV USD 1.82B 76.12M Jun/2025
Ramsay Health Care AUD 3.41B 465.3M Dec/2024
ResMed USD 3.51B 669.42M Jun/2025
Sartorius EUR 2.17B 7.5M Jun/2025
Sino Biopharmaceutical CNY 24.69B 536.66M Dec/2024
Telix Pharmaceuticals AUD 918.56M 663.3M Dec/2024
Tilray USD 707.34M 18.54M Nov/2024
Zz Pientze Pharmaceu 12.29B 113.34M Jun/2025